首页|期刊导航|组织工程与重建外科杂志|胶原酶酶学清创在慢性创面治疗中的应用进展

胶原酶酶学清创在慢性创面治疗中的应用进展OA

Advances in the application of collagenase-based enzymatic debridement for chronic wound management

中文摘要英文摘要

慢性创面已成为全球性公共卫生问题,具有病程长、预后差、患者医疗负担重等特点.清创是创面床准备的核心步骤,直接决定创面治疗的效果.酶学清创是指应用酶类制剂选择性作用于坏死组织,从而达到特异性清创的目的.胶原酶制剂是目前临床应用最广泛、证据最充分的酶学清创制剂,可选择性降解坏死组织胶原,不损伤正常的健康组织,同时具备抗炎、调节创面微环境、促进肉芽组织生长与促进上皮化等多重作用.本文系统回顾酶学清创的发展历史,总结胶原酶制剂的作用机制,及其在烧伤、糖尿病足溃疡、压力性溃疡、血管闭塞性创面等领域的临床应用,并结合最新指南与研究进展进行展望,为临床规范化应用提供依据.

Chronic wounds have emerged as a global public health concern,characterized by prolonged disease course,poor prognosis,and significant patient healthcare burden.Debridement,as a critical step in wound bed preparation,directly determines therapeutic outcomes.Enzymatic debridement refers to the selective application of enzymatic agents to necrotic tissue for targeted debridement.Among these,collagenase-based preparations are the most widely used and evidence-supported enzymatic debridement agents in clinical practice.They selectively degrade necrotic collagen without damaging healthy tissue,while also exerting multiple effects such as anti-inflammatory action,modulation of the wound microenvironment,promotion of granulation tissue formation,and enhancement of epithelialization.This article systematically reviews the historical development of enzymatic debridement,summarizes the mechanisms of collagenase-based preparations,and evaluates their clinical applications in burn wounds,diabetic foot ulcers,pressure ulcers,and vascular occlusive wounds.Furthermore,it provides insights based on the latest guidelines and research advancements to support standardized clinical practice.

陶凯

110032 辽宁省沈阳市 中国医科大学附属第四医院烧伤整形显微外科

医药卫生

酶学清创胶原酶制剂创面愈合烧伤糖尿病足溃疡压力性溃疡血管闭塞性创面创面微环境

Enzymatic debridementCollagenase-based preparationsWound healingBurnsDiabetic foot ulcersPressure ulcersVascular occlusive woundsWound microenvironment

《组织工程与重建外科杂志》 2026 (3)

241-244,4

10.3969/j.issn.1673-0364.2026.03.001

评论